Universal Clinical Codes & Terminology Search

Recording of fetal magnetic cardiac signal using at least 3 channels; patient recording and storage data scanning with signal extraction technical analysis and result as well as supervision review and interpretation of report by a physician or other qualified health care professional

Hereditary prostate cancer-related disorders genomic sequence analysis panel using next-generation sequencing (NGS) Sanger sequencing multiplex ligation-dependent probe amplification (MLPA) and array comparative genomic hybridization (CGH) evaluation of 23 genes and duplications/deletions when indicated pathologic mutations reported with a genetic risk score for prostate cancer

Recording of fetal magnetic cardiac signal using at least 3 channels; patient recording data scanning with raw electronic signal transfer of data and storage

Drug metabolism psychiatry (eg major depressive disorder general anxiety disorder attention deficit hyperactivity disorder [ADHD] schizophrenia) whole blood buccal swab and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis and reported phenotypes

Recording of fetal magnetic cardiac signal using at least 3 channels; signal extraction technical analysis and result

Drug metabolism psychiatry (eg major depressive disorder general anxiety disorder attention deficit hyperactivity disorder [ADHD] schizophrenia) whole blood buccal swab and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis including impacted gene-drug interactions and reported phenotypes

Recording of fetal magnetic cardiac signal using at least 3 channels; review interpretation report by physician or other qualified health care professional

Oncology (non-small cell lung cancer) DNA and RNA digital PCR analysis of 9 genes (EGFR KRAS BRAF ALK ROS1 RET NTRK 1/2/3 ERBB2 and MET) in formalin-fixed paraffin-embedded (FFPE) tissue interrogation for single-nucleotide variants insertions/deletions gene rearrangements and reported as actionable detected variants for therapy selection

Fractional ablative laser fenestration of burn and traumatic scars for functional improvement; first 100 cm2 or part thereof or 1% of body surface area of infants and children

Tau phosphorylated pTau217

Fractional ablative laser fenestration of burn and traumatic scars for functional improvement; each additional 100 cm2 or each additional 1% of body surface area of infants and children or part thereof (List separately in addition to code for primary procedure)

Infectious disease (bacteria viruses fungi and parasites) cerebrospinal fluid (CSF) metagenomic next-generation sequencing (DNA and RNA) bioinformatic analysis with positive pathogen identification

Injection(s) autologous white blood cell concentrate (autologous protein solution) any site including image guidance harvesting and preparation when performed

IDH1 (isocitrate dehydrogenase 1 [NADP+]) IDH2 (isocitrate dehydrogenase 2 [NADP+]) and TERT (telomerase reverse transcriptase) promoter (eg central nervous system [CNS] tumors) next-generation sequencing (single-nucleotide variants [SNV] deletions and insertions)

Absolute quantitation of myocardial blood flow positron emission tomography (PET) rest and stress (List separately in addition to code for primary procedure)

Obstetrics (preeclampsia) biochemical assay of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) serum ratio reported for sFlt-1/PlGF with risk of progression for preeclampsia with severe features within 2 weeks

Transcatheter mitral valve implantation/replacement (TMVI) with prosthetic valve; percutaneous approach including transseptal puncture when performed

Infectious disease (Neisseria gonorrhoeae) sensitivity ciprofloxacin resistance (gyrA S91F point mutation) oral rectal or vaginal swab algorithm reported as probability of fluoroquinolone resistance

Transcatheter mitral valve implantation/replacement (TMVI) with prosthetic valve; transthoracic exposure (eg thoracotomy transapical)

Infectious disease (Mycoplasma genitalium) macrolide sensitivity (23S rRNA point mutation) oral rectal or vaginal swab algorithm reported as probability of macrolide resistance